Literature DB >> 7638998

Outcome of microscopically nonradical, subtotal pancreaticoduodenectomy (Whipple's resection) for treatment of pancreatic head tumors.

M E Reinders1, J H Allema, T M van Gulik, T M Karsten, L T de Wit, P C Verbeek, E J Rauws, D J Gouma.   

Abstract

From 1983 to 1992 a total of 240 patients with a pancreatic head tumor underwent laparotomy to assess the resectability of the tumor. In 44 patients the tumor was not resected because of distant metastases (n = 20) or major vascular involvement or local tumor infiltration (n = 24) not detected during the preoperative workup. A palliative biliary and gastric bypass was performed in these patients. All other patients underwent a subtotal (Whipple's resection, n = 164) or total (n = 32) pancreaticoduo-denectomy. However, in 56 cases after Whipple's resection, microscopic examination of the specimen showed tumor invasion in the dissection margins. For this reason, these resections were considered palliative. We compared hospital mortality, morbidity, and long-term survival of patients who had undergone a biliary and gastric bypass for a locally advanced tumor (group A, n = 24) with a matched group of patients who had undergone a macroscopically radical Whipple's resection that on microscopic examination proved to be nonradical (group B, n = 36). Both groups were comparable with regard to age (mean 61 years in both groups), duration of symptoms (8 weeks in group A and 10 weeks in group B), and tumor size (mean 4.25 cm in group A and 4.30 cm in group B). Median postoperative hospital stay was 18 days in group A and 25 days in group B. Postoperative complications (intraabdominal abscess, gastrointestinal hemorrhage, anastomotic leakage, delayed gastric emptying) occurred in 33% of patients in group A and in 44% of patients in group B. Hospital mortality was 0% and 3% in group A and group B, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7638998     DOI: 10.1007/bf00299174

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 2.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

3.  Treatment of pancreatic carcinoma: the surgeon's dilemma.

Authors:  M Trede
Journal:  Br J Surg       Date:  1987-02       Impact factor: 6.939

4.  Historical review of pancreaticoduodenectomy.

Authors:  J H Peters; L C Carey
Journal:  Am J Surg       Date:  1991-02       Impact factor: 2.565

5.  Cancer of the pancreas: palliative operation, Whipple procedure, or total pancreatectomy.

Authors:  W P Longmire
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

6.  Surgical treatment of pancreatic cancer.

Authors:  A R Moossa; M H Lewis; C R Mackie
Journal:  Mayo Clin Proc       Date:  1979-07       Impact factor: 7.616

7.  Surgical palliation for pancreatic cancer. The UCLA experience.

Authors:  S M Singh; W P Longmire; H A Reber
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

8.  Decreased morbidity and mortality after pancreatoduodenectomy.

Authors:  P A Grace; H A Pitt; R K Tompkins; L DenBesten; W P Longmire
Journal:  Am J Surg       Date:  1986-01       Impact factor: 2.565

9.  Carcinoma of the pancreas and papilla of Vater--assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients.

Authors:  K E Bakkevold; B Arnesjø; B Kambestad
Journal:  Eur J Surg Oncol       Date:  1992-10       Impact factor: 4.424

10.  Current trends in the management of carcinoma of the pancreatic head.

Authors:  J M Funovics; J Karner; T Pratschner; A Fritsch
Journal:  Hepatogastroenterology       Date:  1989-12
View more
  12 in total

Review 1.  Surgical palliation in patients with pancreatic cancer.

Authors:  Jörg Köninger; Moritz N Wente; Michael W Müller; Carsten N Gutt; Helmut Friess; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2006-11-11       Impact factor: 3.445

2.  Computed tomography-based diagnostics might be insufficient in the determination of pancreatic cancer unresectability.

Authors:  Vyacheslav I Egorov; Roman V Petrov; Elena N Solodinina; Gregory G Karmazanovsky; Natalia S Starostina; Natalia A Kuruschkina
Journal:  World J Gastrointest Surg       Date:  2013-04-27

Review 3.  Advanced-stage pancreatic cancer: therapy options.

Authors:  Jens Werner; Stephanie E Combs; Christoph Springfeld; Werner Hartwig; Thilo Hackert; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2013-04-30       Impact factor: 66.675

Review 4.  Surgical resection strategies for locally advanced pancreatic cancer.

Authors:  Alexander Gluth; Jens Werner; Werner Hartwig
Journal:  Langenbecks Arch Surg       Date:  2015-06-27       Impact factor: 3.445

5.  Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma.

Authors:  Harish Lavu; Andres A Mascaro; Dane R Grenda; Patricia K Sauter; Benjamin E Leiby; Sean P Croker; Agnes Witkiewicz; Adam C Berger; Ernest L Rosato; Eugene P Kennedy; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

6.  Pancreatic carcinoma: palliative surgical and endoscopic treatment.

Authors:  D J Gouma; O R C Busch; T M Van Gulik
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

7.  Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Alexander Rehders; Minu Bidde; Sylvia Metz; Matthias Peiper; Claus F Eisenberger; Jan Schulte Am Esch; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2007-08-18       Impact factor: 3.445

8.  Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.

Authors:  Younghwan Kim; Song Cheol Kim; Ki Byoung Song; Jayoun Kim; Dae Ryong Kang; Jae Hoon Lee; Kwang-Min Park; Young-Joo Lee
Journal:  HPB (Oxford)       Date:  2016-02-08       Impact factor: 3.647

9.  R2 resection in pancreatic cancer--does it make sense?

Authors:  Jörg Köninger; Moritz N Wente; Beat P Müller-Stich; Francesco F di Mola; Carsten N Gutt; Ulf Hinz; Michael W Müller; Helmut Friess; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2008-02-29       Impact factor: 3.445

10.  Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Authors:  Thomas Zacharias; Daniel Jaeck; Elie Oussoultzoglou; Agnes Neuville; Philippe Bachellier
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.